Form 4: Ginkgo Bioworks Director Marijn E Dekkers Sells 265,000 Shares

Director Marijn E Dekkers of Ginkgo Bioworks Holdings, Inc. reports selling 265,000 shares of Class A Common Stock at an average price of $0.8303 on May 16, 2024.

Summary

• On May 16, 2024, Marijn E Dekkers, a director of Ginkgo Bioworks Holdings, Inc., sold 265,000 shares of Class A Common Stock.
• The shares were sold at a weighted average price of $0.8303, with individual transactions ranging from $0.8233 to $0.8387.
• Following the transaction, Dekkers directly owns 281,217 shares and indirectly owns 5,515,364 shares through Novalis LifeSciences Investments I, L.P.
• Included in these holdings are earn-out shares that will vest if Ginkgo's Class A Common Stock achieves certain price thresholds by September 16, 2026.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. A director selling shares can sometimes be interpreted negatively, but without further context, it's difficult to assess the full impact. The presence of earn-out shares with price targets suggests some optimism about future performance.

Future Outlook

The vesting of earn-out shares is contingent on Ginkgo Bioworks' Class A Common Stock achieving specific price targets by September 16, 2026.

Industry Context

This filing reflects insider trading activity, which is a common occurrence in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The sale of shares by a director could potentially influence investor sentiment.

Key Dates